Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
Condition: Gastroesophageal Adenocarcinoma Interventions: Drug: Paclitaxel; Drug: Ramucirumab; Drug: Zanidatamab Sponsors: Canadian Cancer Trials Group; Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials